陈玉龙

[1] Hou Y, Zhang X, Sun X, Qin Q, Jia M*, Su X*, Chen Y*. Hepatocyte-specific knockout of YAP protects against atherosclerosis via inhibition of ANGPTL3 in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46:e324122.

[2] Sun X, Zhang Y, Zhang X, Qin Q, Hou Y, Jia M, Su X, Chen Y*. Hepatocyte-specific yes-associated protein knockout exacerbates non-alcoholic steatohepatitis by upregulating PCSK9. Journal of Gastroenterology. 2026;61:625-637.

[3] Zhang X, Yang X, Sun X, Qin Q, Hou Y, Jia M, Su X, Chen Y*. Yes-associated protein in hepatocytes protects against early alcohol-associated liver disease. Liver International. 2025;45:e70372.

[4] Zhang X, Sun X, Qin Q, Hou Y, Jia M, Su X, Chen Y*. YAP-mediated macrophage polarization is involved in progression of atherosclerosis. European Journal of Pharmacology. 2025;1008:178328.

[5] Chen D, Zhang H, Zhang X, Sun X, Qin Q, Hou Y, Jia M, Chen Y*. Roles of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in non-neoplastic liver diseases. Biomedicine & Pharmacotherapy. 2022;151:113166.

[6] Jia M, Su X, Qin Q, Li Y, Wang S, Chen Y*. Tetrahydroxystilbene glucoside attenuated homocysteine-upregulated endothelin receptors in vascular smooth muscle cells via the ERK1/2/NF-κB signaling pathway. Phytotherapy Research. 2022;36:3352-3361.

[7] Hou Y, Zhang X, Sun X, Qin Q, Chen D, Jia M, Chen Y*. Genetically modified rabbit models for cardiovascular medicine. European Journal of Pharmacology. 2022;922:174890.

[8] Jia M, Zhang H, Qin Q, Hou Y, Zhang X, Chen D, Zhang H, Chen Y*. Ferroptosis as a new therapeutic opportunity for nonviral liver disease. European Journal of Pharmacology. 2021;908:174319.

[9] Yu Y, Su X, Qin Q, Hou Y, Zhang X, Zhang H, Jia M, Chen Y*. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases. Pharmacological Research. 2020;159:105009.